Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 2 Trials for Methotrexate (DB00563)

DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed2 IdentifierTitlePurposeDrugs
NCT01789255Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesSupportive Care
NCT01177371High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaTreatment